RecruitingNCT02863757

Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease

Disease Progression and Clinical Outcomes in Chronic Hepatitis B (CHB) Patients With Comorbid Nonalcoholic Fatty Liver Disease (NAFLD)

Sponsor

Humanity and Health Research Centre

Enrollment

1,500 participants

Start Date

Aug 1, 2016

Study Type

OBSERVATIONAL

Conditions

Chronic Hepatitis B Nonalcoholic Fatty Liver Disease

Summary

The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).

Eligibility

Inclusion Criteria3

Liver biopsy proved CHB and/or NAFLD at baseline;
Chinese
Follow-up duration>12 months

Exclusion Criteria6

Other liver diseases;
Secondary causes of hepatic steatosis;
Alcohol abuse;
Liver cirrhosis, cirrhosis related complications or HCC at baseline;
Malignancy;
History of liver transplantation

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Humanity and Health GI and Liver Centre

Hong Kong, Hong Kong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02863757

Related Trials

TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate

NCT065132866 locations

Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease

NCT053309231 location